- জেনেরিক নাম
- Lubiprostone
- শক্তি
- 8 mcg
- ডোজ ফর্ম
- Capsule
- প্রস্তুতকারক
- Renata PLC.
Laxana-8 Soft Gel Capsule Capsule
Laxana-8 Soft Gel Capsule সম্পর্কে
বাংলাদেশে Laxana-8 Soft Gel Capsule ক্যাপসুল হিসেবে পাওয়া যায়; এতে Lubiprostone আছে (৮ mcg)। Lubiprostone-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Renata PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Lubiprostone-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Laxana-8 Soft Gel Capsule কী?
Laxana-8 Soft Gel Capsule is a soft gel capsule containing lubiprostone 8 mcg, made by Renata PLC. It belongs to a group of laxative preparations that work locally in the intestine. It increases secretion of chloride and fluid into the bowel, which helps stool pass more easily. Doctors prescribe it for irritable bowel syndrome with constipation and for certain types of ongoing constipation in adults. The dose and course are decided by the doctor based on the patient's condition. It is not for use in people with suspected or known bowel obstruction.
Laxana-8 Soft Gel Capsule-এর ব্যবহার
Laxana-8 Soft Gel Capsule is used in adults for irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC), and opioid-induced constipation (OIC) in patients with long-term non-cancer pain. It is a locally acting laxative that helps relieve constipation by increasing fluid in the intestine. The doctor decides whether it is suitable for a particular person and for how long it should be taken.
Laxana-8 Soft Gel Capsule কীভাবে ব্যবহার করবেন
Take Laxana-8 Soft Gel Capsule by mouth with food and water, as directed by the doctor. Swallow the soft gel capsule whole; do not crush or chew it unless the doctor or pharmacist says otherwise. The dose and how often to take it are decided by the doctor and depend on the condition being treated. Do not change the dose or stop the medicine without asking the doctor. If you miss a dose, ask the doctor or pharmacist what to do.
Laxana-8 Soft Gel Capsule-এর পার্শ্বপ্রতিক্রিয়া
People taking Laxana-8 Soft Gel Capsule may experience diarrhea, nausea, stomach pain, a full or bloated feeling, swelling of the stomach area, or shortness of breath. Taking the capsule with food may help reduce nausea. If diarrhea is severe or does not stop, or if you have other troublesome symptoms, contact the doctor. The doctor can advise whether the medicine needs to be adjusted or stopped. Do not treat side effects with other medicines without asking a pharmacist first.
সতর্কতা ও নিরাপত্তা
Laxana-8 Soft Gel Capsule should not be used if there is a known or suspected mechanical bowel obstruction. Tell the doctor if you have severe diarrhea before starting this medicine. If you are pregnant, planning pregnancy, or breastfeeding, ask the doctor before using it; it is pregnancy category C and it is not known if it passes into breast milk, so breastfed babies should be monitored for diarrhea. People with liver problems should have their dose decided by the doctor. Keep all medicines out of reach of children and store as directed on the pack.
সাধারণ প্রশ্ন
What does the 8 mcg strength and soft gel capsule form mean?
The strength 8 mcg means each soft gel capsule contains 8 micrograms of lubiprostone. A soft gel capsule is a small, soft shell that is swallowed whole. The doctor will decide the dose and how often you should take it; do not change it yourself.
What is Laxana-8 Soft Gel Capsule used for and what kind of medicine is it?
It is used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in people with long-term non-cancer pain. It is a locally acting laxative that increases fluid secretion in the intestine. The doctor decides if it is right for you.
Which medicines may interact with Laxana-8 Soft Gel Capsule?
There is a possibility that medicines called diphenylheptane opioids may reduce how well lubiprostone works, in a dose-dependent way. Tell your doctor or pharmacist about all medicines you take, including opioids, so they can check for interactions and advise you.
What should I do if I have diarrhea while taking this medicine?
Diarrhea is a possible side effect. If it is severe or does not stop, contact your doctor. Do not take other anti-diarrhea medicines without asking the doctor or pharmacist first. The doctor will decide whether the medicine needs to be adjusted or stopped.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Lubiprostone is indicated in:- Irritable Bowel Syndrome with Constipation (IBS-C).
- Chronic Idiopathic Constipation (CIC) in adults.
- Opioid-Induced Constipation (OIC) in adult patients with chronic, non-cancer pain.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Lubiprostone is a locally-acting chloride-channel activator that increases intestinal secretion. In doing so, it increases intestinal motility, thus aiding the passage of stool and relieve the symptoms associated with chronic idiopathic constipation.Lubiprostone acts by specifically activating ClC-2 chloride channels, which is a normal constituent of the apical membrane of the human intestine, in a protein kinase A action independent fashion. Activation of ClC-2 chloride channels causes an efflux of chloride ions into the lumen, which in turn leads to an efflux of sodium ions through a paracellular pathway to maintain isoelectric neutrality. As a result, water follows sodium into the lumen in order to maintain isotonic equilibrium, thereby increasing intestinal fluid secretion. By increasing intestinal fluid secretion, lubiprostone increases motility in the intestine, thereby increasing the passage of stool and alleviating symptoms associated with chronic idiopathic constipation. Activation of ClC-2 chloride channels may also stimulate the recovery of muscosal barrier function by restoring tight junction protein complexes in the intestine. Patch clamp cell studies in human cell lines have indicated that the majority of the beneficial biological activity of lubiprostone and its metabolites is observed only on the apical (luminal) portion of the gastrointestinal epithelium.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Irritable Bowel Syndrome with Constipation: The recommended dose is 8 mcg twice daily orally with food and water.Dosage in patients with hepatic impairment: Dosage adjustment is not required for patients with moderately impaired hepatic function. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg once daily. If tolerated then dose can be increased to 8 mcg twice
Chronic Idiopathic Constipation and Opioid-induced Constipation: The recommended dose is 24 mcg twice daily orally with food and water.
Dosage in patients with hepatic impairment: For patients with moderately impaired hepatic function, the recommended starting dose is 16 mcg twice daily. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg twice daily.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is a possibility of a dose-dependent decrease in the efficacy of Lubiprostone in patients using diphenylheptane opioids.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Diarrhea, full or bloated feeling or pressure in the stomach, nausea, stomach pain, swelling of abdominal or stomach area, Dyspneaগর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy category C. It is not known whether lubiprostone is excreted in human milk. Because lubiprostone increases fluid secretion in the intestine and intestinal motility, human milk-fed infants should be monitored for diarrhea. Caution should be exercised when Lubiprostone is administered to a nursing woman.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nausea: Patients taking Lubiprostone may experience nausea. Concomitant administration of food with Lubiprostone may reduce symptoms of nausea.Diarrhea: Lubistone should not be prescribed to patients that have severe diarrhea.
Bowel Obstruction: In patients with symptoms suggestive of mechanical gastrointestinal obstruction, perform a thorough evaluation to confirm the absence of an obstruction prior to initiating therapy with Lubiprostone.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adverse reactions due to overdose may include: nausea, diarrhea, vomiting, dizziness, headache, abdominal pain, flushing/hot flash, retching, dyspnea, pallor, stomach discomfort, anorexia, asthenia , chest discomfort, dry mouth, hyperhidrosis , and syncope.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store between 15-30° C.বিকল্প ব্র্যান্ড: Lubiprostone
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।